Physician profile
Mallory Blakeslee
NPI 1932516945
$343.98
in general payments reported to CMS, 2019-2025
8 companies · $37.12 in 2025
The $37.12 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.24 · 2020: $120 · 2021: $15.67 · 2022: $11.68 · 2023: $62.48 · 2024: $85.41 · 2025: $37.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $145.81 | 2019-2023 | Xarelto |
| Abiomed | $107.46 | 2024-2025 | Impella |
| Rare Disease Therapeutics, INC. | $19.58 | 2023 | Anavip |
| Alexion Pharmaceuticals, INC. | $15.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.42 | 2023 | Relistor |
| Chiesi USA, INC. | $15.07 | 2025 | Kengreal, Cleviprex |
| Urgo Medical North America, LLC | $13.29 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Astrazeneca Pharmaceuticals LP | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Blakeslee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.